医学
腹部外科
腹腔镜手术
随机对照试验
协议(科学)
腹腔镜检查
外科
普通外科
麻醉
替代医学
病理
作者
Zhen-feng Zhou,Junbiao Fang,Hongfa Wang,Ying He,Yong-jian Yu,Qiong Xu,Yun-fen Ge,Miaozun Zhang,Shuangfei Hu
出处
期刊:BMJ Open
[BMJ]
日期:2019-10-01
卷期号:9 (10): e028464-e028464
被引量:5
标识
DOI:10.1136/bmjopen-2018-028464
摘要
Introduction Postoperative pulmonary complications (PPCs), strongly associated with higher mortality risk, can develop in up to 58% of patients undergoing abdominal surgery. More and more evidence shows that the use of a lung-protective ventilation strategy has a lung protection effect in patients undergoing abdominal surgery, however, the role of positive end-expiratory pressure (PEEP) during the intraoperative period in preventing PPCs for laparoscopic surgery is not clearly defined. Methods and analysis A total of 208 patients with a high risk of PPC, undergoing laparoscopic abdominal surgery, will be enrolled and randomised into a standard PEEP (6–8 cm H 2 O) group and a low PEEP (≤2 cm H 2 O) group. Both groups will receive a fraction of inspired oxygen of 0.50 and a tidal volume of 8 mL/kg ideal body weight (IBW). Standard perioperative fluid management and analgesic treatments are applied in both groups. The primary end point is PPC within 7 days after surgery. Secondary end points are the modified Clinical Pulmonary Infection Score, postoperative extrapulmonary complications, postoperative surgical complications, intensive care unit length of stay, hospital length of stay, 30-day mortality. Ethics and dissemination The study was approved by the Ethics Committee of Zhejiang Provincial People’s Hospital (People’s Hospital of Hangzhou Medicine College) (registration number KY2018026) on 22 October 2018. The first participant was recruited on 15 April 2019 and the estimated completion date of the study is October 2021. The results of this trial will be submitted to a peer-reviewed journal. Trial registration number http://www.chictr.org.cn , ID: ChiCTR1800019865. Registered on 2 December 2018; preresults.
科研通智能强力驱动
Strongly Powered by AbleSci AI